Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
The Board of Trustees of The University of Alabama has 7 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 7 distinct examiners and 7 distinct art units, so each pending action is associated with a separate examiner and technical-unit assignment in the reported data.
KWON, JOHN SEUNGJAI is the busiest examiner, with 1 pending matter. No examiner has a larger identified workload, which means the docket does not present a dominant examiner concentration.
Counsel should use portfolio-level technical review to maintain consistency while treating each prosecution path independently. The complete distribution across examiners and art units makes centralized issue tracking useful, but does not support relying on one examiner-specific response model.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (29%) |
| §102 only | 1 (14%) |
| Multi-statute (no §101) | 4 (57%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KWON, JOHN SEUNGJAI | 1 | 44.9% | +20.2% |
| EBBINGHAUS, BRIANA NOEL | 1 | 59.7% | +63.0% |
| HIGGINS, GERARD T | 1 | 63.3% | +39.4% |
| LEESER, ERICH A | 1 | 81.9% | +13.3% |
| LOPEZ, LESLIE ANN | 1 | 65.6% | +34.1% |
| BAUM, ZACHARY JOHN | 1 | 81.2% | +15.2% |
| HAUPT, KRISTY A | 1 | 87.9% | +11.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18397327 | NANOPARTICLES WITH ANTI-INFLAMMATORY PROPERTIES AND ENHANCED PENETRATION ACROSS THE BIOLOGICAL BARRIERS TO DELIVER ENCAPSULATED DRUGS | LEESER, ERICH A | — |
| 18505248 | METHOD OF CHEMICAL LOOPING REFORMING AT LOW TEMPERATURES WITH HYDROGEN FROM WATER SPLITTING | BAUM, ZACHARY JOHN | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18959803 | EXOSOMAL COMPOSITIONS INCLUDING ANESTHETICS | KWON, JOHN SEUNGJAI | — |
| 18772579 | SCALABLE BIOMANUFACTURING OF TUMOR ORGANOIDS | EBBINGHAUS, BRIANA NOEL | — |
| 18770905 | MAGNETORHEOLOGICAL EMULSIONS AND METHODS OF MAKING AND USE THEREOF | HIGGINS, GERARD T | — |
| 18498708 | ADAPTIVE POWER SYSTEMS AND CONTROL METHODS WITH STATE-OF-CHARGE OR STATE-OF-ENERGY/POWER BALANCING | HAUPT, KRISTY A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18959803 | EXOSOMAL COMPOSITIONS INCLUDING ANESTHETICS | KWON, JOHN SEUNGJAI | — |
| 18772579 | SCALABLE BIOMANUFACTURING OF TUMOR ORGANOIDS | EBBINGHAUS, BRIANA NOEL | — |
| 18770905 | MAGNETORHEOLOGICAL EMULSIONS AND METHODS OF MAKING AND USE THEREOF | HIGGINS, GERARD T | — |
| 18397327 | NANOPARTICLES WITH ANTI-INFLAMMATORY PROPERTIES AND ENHANCED PENETRATION ACROSS THE BIOLOGICAL BARRIERS TO DELIVER ENCAPSULATED DRUGS | LEESER, ERICH A | — |
| 18523252 | ACTUATORS FOR POWERED PROSTHESES | LOPEZ, LESLIE ANN | — |
| 18505248 | METHOD OF CHEMICAL LOOPING REFORMING AT LOW TEMPERATURES WITH HYDROGEN FROM WATER SPLITTING | BAUM, ZACHARY JOHN | — |
| 18498708 | ADAPTIVE POWER SYSTEMS AND CONTROL METHODS WITH STATE-OF-CHARGE OR STATE-OF-ENERGY/POWER BALANCING | HAUPT, KRISTY A | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| 1632 | 1 |
| 1785 | 1 |
| 1622 | 1 |
| 3774 | 1 |
| 1736 | 1 |
| 2876 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18959803 | EXOSOMAL COMPOSITIONS INCLUDING ANESTHETICS | KWON, JOHN SEUNGJAI | 1615 | §102§103§112 | Non-Final OA | — | Pending | Nov 26, 2024 |
| 18772579 | SCALABLE BIOMANUFACTURING OF TUMOR ORGANOIDS | EBBINGHAUS, BRIANA NOEL | 1632 | §102§103§112 | Non-Final OA | — | Pending | Jul 15, 2024 |
| 18770905 | MAGNETORHEOLOGICAL EMULSIONS AND METHODS OF MAKING AND USE THEREOF | HIGGINS, GERARD T | 1785 | §102§103§112 | Non-Final OA | — | Pending | Jul 12, 2024 |
| 18397327 | NANOPARTICLES WITH ANTI-INFLAMMATORY PROPERTIES AND ENHANCED PENETRATION ACROSS THE BIOLOGICAL BARRIERS TO DELIVER ENCAPSULATED DRUGS | LEESER, ERICH A | 1622 | §102 | Non-Final OA | — | Pending | Dec 27, 2023 |
| 18523252 | ACTUATORS FOR POWERED PROSTHESES | LOPEZ, LESLIE ANN | 3774 | §103 | Final Rejection | — | Pending | Nov 29, 2023 |
| 18505248 | METHOD OF CHEMICAL LOOPING REFORMING AT LOW TEMPERATURES WITH HYDROGEN FROM WATER SPLITTING | BAUM, ZACHARY JOHN | 1736 | §103 | Non-Final OA | — | Pending | Nov 09, 2023 |
| 18498708 | ADAPTIVE POWER SYSTEMS AND CONTROL METHODS WITH STATE-OF-CHARGE OR STATE-OF-ENERGY/POWER BALANCING | HAUPT, KRISTY A | 2876 | §102§103 | Non-Final OA | — | Pending | Oct 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Board of Trustees of The University of Alabama has 7 pending office actions as of October 2026, spread across 7 art units and 7 examiners.
John Seungjai Kwon has the most, with 1 of The Board of Trustees of The University of Alabama's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
